CVRx, Inc.

CVRX
$5.85 (+ $0.60 + 11.43%)
Last updated: 2026-06-27 15:00 UTC
CVRX Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS1266381052
CUSIP126638105
Market Price5.85
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.99
Market Cap$201.7M
Book Value1.83
Price to Book4.193
Beta1.25
52w High18.55
52w Low4.3
Next Earnings DateN/A

CVRx, Inc. trades under ticker CVRX on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1266381052, CUSIP 126638105.

About the Company
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Price History